Single-arm,Two Phase,Multicenter Trial to Evaluating the Efficacy and Safety of the CAR-T for Stomach Cancer
Phase of Trial: Phase I/II
Latest Information Update: 27 Mar 2017
At a glance
- Drugs EPCAM-targeted CAR-T cells (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- Sponsors Sinobioway Cell Therapy
- 21 Mar 2017 Status changed from suspended to recruiting.
- 13 Mar 2017 Planned End Date changed from 1 May 2019 to 1 Nov 2019.
- 13 Mar 2017 Planned primary completion date changed from 1 Oct 2016 to 1 Nov 2019.